Evidence map›Paper›PMID 35815194›Full record

ArticleBioinformation2022

Insights from the molecular docking analysis of colistin with the PmrA protein model from Acinetobacter baumannii.

Shalini Ganeshan, Mohammad Reza Shakibaie, Rajaguru Rajagopal

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioinformation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shalini GaneshanDepartment of Biotechnology, Tips college of arts and science, Coimbatore, Tamil Nadu 641107, India.
Mohammad Reza ShakibaieDepartment of Microbiology and Virology, Kerman University of Medical Sciences, Kerman, Iran.
Rajaguru RajagopalResearch Scholar Department of Pharmaceutics, Mother Theresa Post Graduate and Research Institute of Health Sciences, Pondicherry-605006, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acinetobacter baumannii (AB) is one of the most common causes of nosocomial infections. Therefore, it is of interest to design and develop drugs against Acinetobacter baumannii. A strain of AB showing MIC 32 µg/ml against colistin was isolated from a hospital environment in Iran. Hence, we document data to glean insights from the molecular docking analysis of colistin with the PmrA protein from this bacterium.

Indexed as

Acinetobacter baumanniimodel qualitymolecular dockingprotein modeling

Identifiers

PMID35815194
PMCPMC9200612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.